TuisTKPHF ā¢ OTCMKTS
add
Takeda Pharmaceutical Co Ltd
Vorige sluiting
$26,17
Dagwisseling
$24,25 - $24,25
Jaarwisseling
$23,80 - $30,90
Markkapitalisasie
41,75Ā mjd USD
Gemiddelde volume
8,45Ā k
P/V-verhouding
-
Dividend-opbrengs
-
PrimĆŖre beurs
TYO
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(JPY) | Sep. 2024info | J/J-verandering |
---|---|---|
Inkomste | 1,18Ā bn | 12,75% |
Bedryfskoste | 540,19Ā mjd | -10,33% |
Netto inkomste | 92,05Ā mjd | 291,64% |
Netto winsgrens | 7,83 | 270,22% |
Wins per aandeel | ā | ā |
EBITDA | 433,99Ā mjd | 55,12% |
Effektiewe belastingkoers | 22,84% | ā |
Balansstaat
Totale bates
Totale aanspreeklikheid
(JPY) | Sep. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 859,02Ā mjd | 170,09% |
Totale bates | 14,57Ā bn | -2,01% |
Totale aanspreeklikheid | 7,65Ā bn | -1,92% |
Totale ekwiteit | 6,92Ā bn | ā |
Uitstaande aandele | 1,59Ā mjd | ā |
Prys om te bespreek | 0,01 | ā |
Opbrengs op bates | 3,92% | ā |
Opbrengs op kapitaal | 4,57% | ā |
Kontantvloei
Netto kontantverandering
(JPY) | Sep. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | 92,05Ā mjd | 291,64% |
Kontant van bedrywe | 280,96Ā mjd | 41,25% |
Kontant van beleggings | -75,13Ā mjd | -24,02% |
Kontant van finansiering | -110,04Ā mjd | 21,76% |
Netto kontantverandering | 54,00Ā mjd | 3Ā 129,84% |
Beskikbare kontantvloei | 97,22Ā mjd | -39,87% |
Meer oor
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. Wikipedia
Gestig
12 Jun. 1781
Webwerf
Werknemers
49Ā 281